News

Arnold & Porter Welcomes Litigator John F. Hagan, Jr. to Chicago Office

February 11, 2019

CHICAGO, February 11, 2019 — Arnold & Porter announced today that John Hagan has joined the firm as a partner in the Litigation Group. He will be resident in the Chicago office.

An experienced trial attorney, Mr. Hagan has a broad-based litigation practice that includes general commercial, class actions, bankruptcy, product liability, toxic tort, antitrust, and intellectual property litigation. He has served as lead trial counsel for Fortune 100 companies and smaller entities alike, appearing in state and federal courts throughout the country, as well as in arbitration proceedings. Mr. Hagan has represented clients across a range of industries, including financial services, media and entertainment, pharmaceuticals and life sciences, aerospace and defense, and insurance.

"We are very pleased to welcome John to our firm," said D. Tyler Nurnberg, Head of Arnold & Porter's Chicago office. "His considerable litigation experience complements the strength of our firmwide capability and deepens the Chicago-based resources available to clients."

John has also developed a unique proficiency for prosecuting and, if necessary, trying various breach of contract and breach of warranty cases arising under Article 2 of the Uniform Commercial Code that frequently involve the introduction of complex engineering-related evidence.

"Experienced across a number of key industries, John brings deep litigation and trial strength to the firm," said James D. Herschlein, co-chair of the firm's Litigation Group. "He will be an invaluable asset to our team."

Mr. Hagan earned his JD from New York University School of Law and his BA from the University of Chicago, where he graduated Phi Beta Kappa.

About Arnold & Porter

With more than 1,000 lawyers practicing in 14 offices around the globe, Arnold & Porter serves clients across 40 distinct practice areas. The firm offers 100 years of renowned regulatory expertise, sophisticated litigation and transactional practices, and leading multidisciplinary offerings in the life sciences and financial services industries.

Email Disclaimer